Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


ViaCyte Receives More Funding for Diabetes Stem Cell Therapy 

 

ViaCyte Receives More Funding for Diabetes Stem Cell Therapy

February 13, 2013 - (ViaCyte) - "JDRF, a global organization focused on type 1 diabetes (T1D) research, and the California Institute for Regenerative Medicine (CIRM) agreed to provide additional funding for the development of a novel stem cell therapy by ViaCyte. JDRF and CIRM will each contribute $3 million to further advance the project." Read Full Press Release

 

 

 

 

Posted on 14-Feb-13 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: